Nuclear Medicine Market Trends

  • Report ID: 4456
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Nuclear Medicine Market Trends

Growth Drivers

  • Growing Prevalence of Cardiovascular Diseases- According to the World Health Organization, 17.9 million deaths worldwide in 2019 were attributable to CVDs, or 32% of all fatalities. Heart attack and stroke deaths accounted for 85% of these fatalities.
  • Globally, cardiovascular diseases (CVDs) are the leading cause of death. Nuclear imaging technology is becoming more and more important in the early detection of many disorders. It is utilised to enhance patient "outcomes," which entails that early and accurate disease diagnosis informs efficient treatment and results in a quicker, more thorough recovery from illness. Hence owing to this market is expected to grow in the forecast period.
  • Growing Geriatric Population- According to the World Health Organization, one in six individuals worldwide would be 60 or older by the year 2030.
  • New Product Launches by Key Players - GE Healthcare Launches StarGuide, a New Nuclear Medicine System to Aid in the Advancement of Precision Health and Theranostics.
  • Increasing Cancer Cases  - It is anticipated that by 2040, there would be 16.4 million cancer-related deaths and 29.5 million new instances of cancer annually.
  • Technology Advancement - According to a report published on March 7 in Science Translational Medicine, a new PET imaging agent is expected help patients with non-small cell lung cancer (NSCLC) choose the most beneficial course of treatment (who make up about 80 percent of lung cancer patients). The tracer looks for a mutation that is unique to NSCLC instances, possibly being able to show areas of the cancer that are vulnerable to certain treatment medications that could block the effects of the mutation.

Challenges

  • Availability of Alternatives
  • Limited Number of Trained Medical Professional
  • Supply Shortage
  • There are various alternatives available for nuclear medicine such has MRI and CT scanner. They are less preferred because their price is high as compared to MRI and CT scanner. Hence this factor is expected to be the major hindrance for the growth of the market.

Nuclear Medicine Market: Key Insights

Growth Drivers

  • Growing Prevalence of Cardiovascular Diseases- According to the World Health Organization, 17.9 million deaths worldwide in 2019 were attributable to CVDs, or 32% of all fatalities. Heart attack and stroke deaths accounted for 85% of these fatalities.

Globally, cardiovascular diseases (CVDs) are the leading cause of death. Nuclear imaging technology is becoming more and more important in the early detection of many disorders. It is utilised to enhance patient "outcomes," which entails that early and accurate disease diagnosis informs efficient treatment and results in a quicker, more thorough recovery from illness. Hence owing to this market is expected to grow in the forecast period.

  • Growing Geriatric Population- According to the World Health Organization, one in six individuals worldwide would be 60 or older by the year 2030.

  • New Product Launches by Key Players - GE Healthcare Launches StarGuide, a New Nuclear Medicine System to Aid in the Advancement of Precision Health and Theranostics.

  • Increasing Cancer Cases  - It is anticipated that by 2040, there would be 16.4 million cancer-related deaths and 29.5 million new instances of cancer annually.

  • Technology Advancement - According to a report published on March 7 in Science Translational Medicine, a new PET imaging agent is expected help patients with non-small cell lung cancer (NSCLC) choose the most beneficial course of treatment (who make up about 80 percent of lung cancer patients). The tracer looks for a mutation that is unique to NSCLC instances, possibly being able to show areas of the cancer that are vulnerable to certain treatment medications that could block the effects of the mutation.

Challenges

  • Availability of Alternatives
  • Limited Number of Trained Medical Professional
  • Supply Shortage

There are various alternatives available for nuclear medicine such has MRI and CT scanner. They are less preferred because their price is high as compared to MRI and CT scanner. Hence this factor is expected to be the major hindrance for the growth of the market.

The global nuclear medicine market is segmented and analysed fir demand and supply by application into cardiology, neurology, and oncology. Out of which, the oncology segment is anticipated to garner the largest revenue by the end of 2033, backed by growing population who are prone to smoking. According to the World Health Organization, in 2020, 36.7% of all men and 7.8% of all women consumed cigarettes. This represents 22.3% of the world's population. Smoking is the main cause of growing prevalence of cancer all around the world which is further expected to boost the growth of the market. As per the World Health Organization, the use of tobacco, having a high body mass index, drinking alcohol, eating few fruits and vegetables, and not exercising account for about one-third of cancer-related fatalities.

Base Year

2024

Forecast Year

2025-2037

CAGR

20.1%

Base Year Market Size (2024)

USD 12.94 billion

Forecast Year Market Size (2037)

USD 143.71 billion

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4456
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of nuclear medicine is estimated at USD 15.04 billion.

The nuclear medicine market size was over USD 12.94 billion in 2024 and is set to cross USD 143.71 billion by the end of 2037, growing at more than 20.1% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of cardiovascular diseases, growing geriatric population, new product launches by key players, and others.

Asia Pacific industry is poised to dominate majority revenue share by 2037, owing to increasing awareness about nuclear medicine and growing investment in nuclear medicine space in the region.

The major players in the market include GE Healthcare, Jubilant Pharmova Limited, Nordion (Canada), Inc., Bracco Imaging S.P.A, The Institute for Radioelements (IRE), NTP Radioisotopes SOC Ltd., The Australian Nuclear Science and Technology Organization (ANSTO), Mallinckrodt Pharmaceuticals, Lantheus, Eckert & Ziegler.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample